Notes - Segment Information, Etc.

OncoTherapy Science, Inc. - Filing #7604688

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
1,153,663,000 JPY
JPY
1,153,663,000 JPY
7,165,000 JPY
1,146,498,000 JPY
332,477,000 JPY
110,993,000 JPY
221,484,000 JPY
JPY
332,477,000 JPY
Transactions with other segments
8,500,000 JPY
-8,500,000 JPY
JPY
166,000 JPY
8,333,000 JPY
50,120,000 JPY
55,000 JPY
50,064,000 JPY
-50,120,000 JPY
JPY
Other items
Depreciation
11,025,000 JPY
5,515,000 JPY
16,540,000 JPY
11,025,000 JPY
JPY
34,305,000 JPY
34,305,000 JPY
JPY
14,703,000 JPY
49,008,000 JPY
Increase in property, plant and equipment and intangible assets
469,420,000 JPY
952,000 JPY
470,372,000 JPY
1,680,000 JPY
467,740,000 JPY
12,720,000 JPY
1,899,000 JPY
10,821,000 JPY
29,238,000 JPY
41,959,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.